Zetia Wholesalers Denied Class Cert. In Generics-Delay Suit

By Bryan Koenig (April 14, 2022, 7:37 PM EDT) -- A group of wholesalers accusing Merck and Glenmark Pharmaceuticals of a scheme to delay a generic cholesterol drug are unlikely to force a settlement on the companies after a Virginia federal judge refused to certify a proposed class to pursue the claims....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!